Valeant CEO says he, company were 'too aggressive' in boosting drug prices
Wednesday, April 27, 2016 - 11:40
in Mathematics & Economics
Valeant Pharmaceutical's soon-to-be-former CEO, J. Michael Pearson, is to tell U.S. Senate committee that he and the company were 'too aggressive' in bumping up prices on some of its drug products.